GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » Total Long-Term Assets

Mercury Biopharmaceutical (ROCO:6932) Total Long-Term Assets : NT$110.30 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Mercury Biopharmaceutical Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Mercury Biopharmaceutical's Total Long-Term Assets for the quarter that ended in Dec. 2024 was NT$110.30 Mil.

Mercury Biopharmaceutical Total Long-Term Assets Historical Data

The historical data trend for Mercury Biopharmaceutical's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Biopharmaceutical Total Long-Term Assets Chart

Mercury Biopharmaceutical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Assets
Get a 7-Day Free Trial - 9.46 84.20 98.15 110.30

Mercury Biopharmaceutical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.20 93.33 98.15 103.30 110.30

Mercury Biopharmaceutical Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Mercury Biopharmaceutical Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mercury Biopharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » Total Long-Term Assets
Comparable Companies
ROCO:4120 ROCO:1799 ROCO:4166 TPE:1731 ROCO:4747 TPE:4108 ROCO:4132 TPE:4746 TPE:4119 ROCO:1796 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 653-1, Bannan Road, 15th Floor, Zhonghe District, New Taipei City, TWN
Website
https://www.merdury.com.tw
Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.

Mercury Biopharmaceutical Headlines

No Headlines